Table 2. Analysis of efficacy in full analysis set.
UFT group (n = 29) | OBS group (n = 29) | P | |
---|---|---|---|
PFS | |||
Disease progression or death, No. | 25 | 26 | |
Median (95% CI), months | 3.2 (1.4 to 5.0) | 3.6 (1.7 to 5.5) | 0.752 |
OS | |||
Death, No. | 19 | 21 | |
Median (95% CI), months | 14.2 (11.1 to 17.3 ) | 14.2 (8.2 to 20.3) | 0.983 |
Abbreviations: PFS, progression-free survival; OS, overall survival.